These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33047206)

  • 21. Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort study.
    Yoo C; Yun MR; Ahn JH; Jung KH; Kim HJ; Kim JE; Park JY; Park KO; Yoon DH; Kim SB
    Cancer Chemother Pharmacol; 2013 Sep; 72(3):565-75. PubMed ID: 23842722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of chemotherapy-induced ovarian failure in premenopausal women undergoing chemotherapy for breast cancer.
    Tiong V; Rozita AM; Taib NA; Yip CH; Ng CH
    World J Surg; 2014 Sep; 38(9):2288-96. PubMed ID: 24700093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy-induced amenorrhea and fertility in women undergoing adjuvant treatment for breast cancer.
    Minton SE; Munster PN
    Cancer Control; 2002; 9(6):466-72. PubMed ID: 12514564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of chemotherapy-induced amenorrhea in premenopausal women treated with adjuvant FOLFOX for colorectal cancer.
    Cercek A; Siegel CL; Capanu M; Reidy-Lagunes D; Saltz LB
    Clin Colorectal Cancer; 2013 Sep; 12(3):163-7. PubMed ID: 23871161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer.
    Abusief ME; Missmer SA; Ginsburg ES; Weeks JC; Partridge AH
    Cancer; 2010 Feb; 116(4):791-8. PubMed ID: 20052714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients.
    Poikonen P; Saarto T; Elomaa I; Joensuu H; Blomqvist C
    Eur J Cancer; 2000 Jan; 36(1):43-8. PubMed ID: 10741293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer.
    Lambertini M; Del Mastro L; Viglietti G; Pondé NF; Solinas C; de Azambuja E
    Curr Treat Options Oncol; 2017 Jan; 18(1):4. PubMed ID: 28185173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer.
    Bines J; Oleske DM; Cobleigh MA
    J Clin Oncol; 1996 May; 14(5):1718-29. PubMed ID: 8622093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NSAS-BC02 substudy of chemotherapy-induced amenorrhea (CIA) in premenopausal patients who received either taxane alone or doxorubicin(A) cyclophosphamide(C) followed by taxane as postoperative chemotherapy.
    Iwamoto T; Hara F; Uemura Y; Mukai H; Watanabe T; Ohashi Y
    Breast Cancer Res Treat; 2020 Jul; 182(2):325-332. PubMed ID: 32462261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
    Sharma R; Hamilton A; Beith J
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004562. PubMed ID: 18843661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.
    Munhoz RR; Pereira AA; Sasse AD; Hoff PM; Traina TA; Hudis CA; Marques RJ
    JAMA Oncol; 2016 Jan; 2(1):65-73. PubMed ID: 26426573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial).
    Ruddy KJ; Guo H; Barry W; Dang CT; Yardley DA; Moy B; Marcom PK; Albain KS; Rugo HS; Ellis MJ; Shapira I; Wolff AC; Carey LA; Overmoyer BA; Hudis C; Krop IE; Burstein HJ; Winer EP; Partridge AH; Tolaney SM
    Breast Cancer Res Treat; 2015 Jun; 151(3):589-96. PubMed ID: 25981899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhoea: caution and suggested guidelines.
    Smith IE; Dowsett M; Yap YS; Walsh G; Lønning PE; Santen RJ; Hayes D
    J Clin Oncol; 2006 Jun; 24(16):2444-7. PubMed ID: 16735701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant chemotherapy in early breast cancer.
    Ejlertsen B
    Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI.
    Partridge A; Gelber S; Gelber RD; Castiglione-Gertsch M; Goldhirsch A; Winer E
    Eur J Cancer; 2007 Jul; 43(11):1646-53. PubMed ID: 17512721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study.
    Jonat W; Kaufmann M; Sauerbrei W; Blamey R; Cuzick J; Namer M; Fogelman I; de Haes JC; de Matteis A; Stewart A; Eiermann W; Szakolczai I; Palmer M; Schumacher M; Geberth M; Lisboa B;
    J Clin Oncol; 2002 Dec; 20(24):4628-35. PubMed ID: 12488406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Effects of Adjuvant Chemotherapy-Induced Amenorrhea and Subsequent Resumption of Menstruation for Premenopausal Breast Cancer Patients.
    Jeon SJ; Lee JI; Jeon MJ; Lee M
    Medicine (Baltimore); 2016 Apr; 95(14):e3301. PubMed ID: 27057900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial).
    Ruddy KJ; Zheng Y; Tayob N; Hu J; Dang CT; Yardley DA; Isakoff SJ; Valero VV; Faggen MG; Mulvey TM; Bose R; Sella T; Weckstein DJ; Wolff AC; Reeder-Hayes KE; Rugo HS; Ramaswamy B; Zuckerman DS; Hart LL; Gadi VK; Constantine M; Cheng KL; Briccetti FM; Schneider BP; Merrill Garrett A; Kelly Marcom P; Albain KS; DeFusco PA; Tung NM; Ardman BM; Nanda R; Jankowitz RC; Rimawi M; Abramson V; Pohlmann PR; Van Poznak C; Forero-Torres A; Liu MC; Rosenberg S; DeMeo MK; Burstein HJ; Winer EP; Krop IE; Partridge AH; Tolaney SM
    Breast Cancer Res Treat; 2021 Aug; 189(1):103-110. PubMed ID: 34120223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotherapy-induced amenorrhea in patients with breast cancer with a BRCA1 or BRCA2 mutation.
    Valentini A; Finch A; Lubinski J; Byrski T; Ghadirian P; Kim-Sing C; Lynch HT; Ainsworth PJ; Neuhausen SL; Greenblatt E; Singer C; Sun P; Narod SA
    J Clin Oncol; 2013 Nov; 31(31):3914-9. PubMed ID: 23980083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.